Elevated levels of serum lipoprotein(a) and apolipoprotein(a) phenotype are not related to pre-eclampsia

References

• Khong T Y, De Wolf F, Robertson W B, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 1986; 93: 1049–59
   PubMedGoogle Scholar
• Clark D A, Vince G, Flanders K C, Hirte H. Starkey P CD56+ lymphoid cells in human first trimester pregnancy decidua as a source of novel TGF-p-related immunosuppressive factors. Hum Reprod 1994; 9: 2270–7
   Google Scholar
• Sato Y, Tsuboi R, Lyons R, Moses H, Rifkin D B. Characterization of the activation of latent TGF-β by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self regulating system. J Cell Biol 1990; 111: 757–63
   PubMed Web of Science ®Google Scholar
• McLean J W, Tomlinson J E, Kuang W-J, Eaton D L, Chen K Y, Fless G M, et al. cDNA sequence of human apolipopro-tein(a) is homologous to plasminogen. Nature 1987; 300: 132–7
   Web of Science ®Google Scholar
• Marcovina S M, Zu H Z, Gaur V P, Albers J J. Identification of 34 apolipoprotein(a) isoforms: differential expression of apolipoprotein(a) alleles between American blacks and whites. Biochem Biophys Res Com 1993; 191: 1192–6
   PubMed Web of Science ®Google Scholar
• Loscalzo J, Weinfeld M, Fless G M, Scanu A M. Lipopro-tein(a), fibrin binding, and plasminogen activation. Arteriosclerosis 1990; 10: 240–5
   PubMedGoogle Scholar
• Leerink C B, Gimpel J A, Kortlandt W, Bouma B N, Van Rijn H J M. Kinetic analysis of lipoprotein(a) inhibition of plasminogen activation by tissue plasminogen activator, in vitro. Fibrinolysis 1991; 5: 233–7
   Google Scholar
• Hajjar K A, Gavish D, Breslow J L, Nachman R L. Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature 1989; 339: 303–5
   PubMed Web of Science ®Google Scholar
• Miles L A, Fless G M, Levin K G, Scanu A M, Plow E F. A potential basis for the thrombotic risks associated with lipoprotein(a). Nature 1989; 339: 301–3
   PubMed Web of Science ®Google Scholar
• Hervio L, Chapman J M, Thillet J, Loyau S, Angles-Cano E. Does apolipoprotein(a) heterogeneity influence lipopro-tein(a) effects on fibrinolysis?. Blood 1993; 82: 392–7
   PubMedGoogle Scholar
• Leerink C B, Duif P F C C M, Verhoeven N, Hackeng C M, Leus F R, Prins J L, et al. Apolipoprotein(a) isoform size influences binding of lipoprotein(a) to plasmin-modified des-AA-fibrinogen. Fibrinolysis 1994; 8: 214–20
   Google Scholar
• Kojima S, Harpel P C, Rifkin D B. Lipoprotein(a) inhibits the generation of transforming growth factor β an endogenous inhibitor of smooth muscle cell migration. J Cell Biol 1991; 113: 1439–5
   PubMed Web of Science ®Google Scholar
• Grainger D J, Kemp P R, Liu A C, Lawn R M, Metcalfe J C. Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein(a) mice. Nature 1994; 370: 460–2
   PubMed Web of Science ®Google Scholar
• Meekins J W, Pijnenborg R, Hanssens M, Van Assche A, McFadyen I R. Immunohistochemical detection of lipoprotein(a) in the wall of placental bed spiral arteries in normal and severe pre-eclamptic pregnancies. Placenta 1994; 15: 511–24
   PubMed Web of Science ®Google Scholar
• Davey D, MacGillivray I M. The classification and definition of hypertensive disorders of pregnancy. Clin Exp Hyper Pregnancy 1986; 5: 97–113
   Google Scholar
• Maeda S, Abe A, Seishima M, Makino K, Noma A, Kawa-De M. Transient changes of lipoprotein(a) as an acute phase protein. Atherosclerosis 1989; 78: 145–50
   PubMed Web of Science ®Google Scholar
• Taddei-Peters W C, Butman B T, Jones G, Venetta T M, Ma-Comber P F, Ransom J H. Quantification of lipoprotein(a) particles containing various apolipoprotein(a) isoforms by a monoclonal anti-apo(a) capture antibody and a polyclonal anti-apolipoprotein B detection antibody sandwich enzyme immunoassay. Clin Chem 1993; 39: 1382–92
   PubMedGoogle Scholar
• Kamboh M I, Ferrell R E, Kottke B A. Expressed hypervari-able polymorphism of apolipoprotein(a). Am J Hum Genet 1991; 49: 1063–74
   PubMed Web of Science ®Google Scholar
• Pijnenborg R, Anthony J, Davey D A, Rees A, Tiltman A, Vercruysse L, et al. Placental bed spiral arteries in hypertensive disorders of pregnancy. Br J Obstet Gynaecol 1991; 98: 648–55
   PubMedGoogle Scholar
• Jenner J L, Ordovas J M, Lamon-Fava S, Schaefer M M, Wilson P W F, Castelli W P, et al. Effects of age, sex, and menopausal status on plasma lipoprotein(a) levels. The Framingham offspring study. Circulation 1993; 87: 1135–41
   PubMed Web of Science ®Google Scholar
• Karadi I, Romics L, Palos G. Lp(a) lipoprotein concentration in scrum of patients with heavy proteinuria of different origin. Clin Chem 1989; 35: 2121–3
   PubMed Web of Science ®Google Scholar